FDA-Drug2020-01-22Class II
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.
Hikma Pharmaceuticals USA Inc.
Hazard
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
Sold states
Nationwide within the United States
Affected count
25,817 shelf packs/25 vials per pack
Manufactured in
2 Esterbrook Ln, Cherry Hill, NJ, United States
Products
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0658-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief